COMMUNIQUÉS West-GlobeNewswire

OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock
26/03/2019
GAITHERSBURG, Md., March 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today the pricing of an underwritten public offering of 9 million shares of its common stock at a public offering price of $0. [...]
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
26/03/2019
Jeff Elliott adds relevant experience to Exagen’s Board of Directors as a former diagnostics analyst at Robert W. Baird & Co. as well as the current CFO of Exact Sciences San Diego, CA and Albuquerque, NM, March 26 [...]
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Featured in NetworkNewsWire Publication on Soaring Hemp-Based CBD Industry
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Wildflower Brands [...]
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
26/03/2019
LAVAL, Quebec, March 26, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
26/03/2019
First Latin American Approval of Crysvita, the only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease NOVATO, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc [...]
Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program
26/03/2019
Complete Enrollment of Phase 2 Trial to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 Administered by Epidural Injection in Subjects with Lumbosacral Radiculopathy, a.k.a. sciatica All subjects [...]
Agritek Holdings, Inc. Announces Proposed Purchase Agreement for Licensed Cannabis Cultivation and Manufacturing Facility in San Juan, Puerto Rico
26/03/2019
LOS ANGELES, CA, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTCQB: AGTKD) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]
Protech Home Medical Announces Redemption of 7.5% Non-Convertible Unsecured Subordinated Debentures
26/03/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Ohio, March 26, 2019 (GLOBE NEWSWIRE) -- Protech [...]
Vectura Group plc 2018 Preliminary Results
26/03/2019
This contains inside information 2018 Preliminary Results - Vectura reports strong 2018 financial and operational performance - Chippenham, UK – 26 March 2019 : Vectura Group plc (LSE: VEC) ("Vectura" or "the Group") [...]
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer
26/03/2019
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer Gosselies, Belgium and Cambridge, MA – March 26, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel [...]
Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia
26/03/2019
Oxford Biomedica notes the Japanese approval of Kymriah ® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia Oxford, UK – 26 March 2019: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy [...]
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
26/03/2019
EAST RUTHERFORD, N.J., March 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018
26/03/2019
YAVNE, Israel, March 26, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Notification from Oasmia Pharmaceutical AB
26/03/2019
Notification from Oasmia Pharmaceutical AB Uppsala, Sweden, March 26, 2019 – The Swedish Securities Council has today published a statement regarding Oasmia. For statement please click here (only in Swedish). About [...]
Matinas BioPharma to Announce Full-Year 2018 Operational and Financial Results on April 2, 2019
26/03/2019
Conference call and live audio webcast on Tuesday, April 2nd at 8:00 a.m. ET BEDMINSTER, N.J., March 26, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical [...]
Blissco Signs Agreement to Supply New Brunswick with Premium Cannabis
26/03/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, March 26, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Predictive Technology Group Completes Acquisition of Taueret Laboratories
26/03/2019
Addition of CAP/CLIA laboratory and experienced diagnostics team form an unparalleled molecular clinical and research facility to accelerate new product development, commercialization and scale SALT LAKE CITY, March 26 [...]
iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit
26/03/2019
NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief [...]
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
26/03/2019
Phase 1b SLE top-line data and Phase 2 LN initiation in Q2 2019 Phase 2 trials in up to four additional autoimmune indications to begin 2H 2019 First clinical candidate nomination for protein secretion program in 2019 [...]

Pages